Feasibility of oral administration of S-1 as adjuvant chemotherapy in gastric cancer: 4-week S-1 administration followed by 2-week rest vs. 2-week administration followed by 1-week rest

In 2006, the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer (ACTS-GC) demonstrated that S-1 is an effective adjuvant therapy for gastric cancer. Following that study, S-1 has been used as the standard adjuvant therapy for gastric cancer in Japan. However, the 1-year completion rate was only 6...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Mol Clin Oncol
المؤلفون الرئيسيون: YAMATSUJI, TOMOKI, FUJIWARA, YASUHIRO, MATSUMOTO, HIDEO, HATO, SHINJI, NAMIKAWA, TSUTOMU, HANAZAKI, KAZUHIRO, TAKAOKA, MUNENORI, HAYASHI, JIRO, SHIGEMITSU, KAORI, YOSHIDA, KAZUHIRO, URAKAMI, ATSUSHI, UNO, FUTOSHI, NISHIZAKI, MASAHIKO, KAGAWA, SHUNSUKE, NINOMIYA, MOTOKI, FUJIWARA, TOSHIYOSHI, HIRAI, TOSHIHIRO, NAKAMURA, MASAFUMI, HAISA, MINORU, NAOMOTO, YOSHIO
التنسيق: Artigo
اللغة:Inglês
منشور في: D.A. Spandidos 2015
الموضوعات:
Articles
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4471633/
https://ncbi.nlm.nih.gov/pubmed/26137261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.500
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة